D
Deborah Watson-Jones
Researcher at University of London
Publications - 135
Citations - 7347
Deborah Watson-Jones is an academic researcher from University of London. The author has contributed to research in topics: Population & Vaccination. The author has an hindex of 42, co-authored 116 publications receiving 6143 citations. Previous affiliations of Deborah Watson-Jones include Amref Health Africa & National Institute for Medical Research.
Papers
More filters
Journal ArticleDOI
Uptake of voluntary counselling and testing among young people participating in an HIV prevention trial: comparison of opt-out and opt-in strategies.
Kathy Baisley,Aoife M. Doyle,Aoife M. Doyle,John Changalucha,Kaballa Maganja,Deborah Watson-Jones,Deborah Watson-Jones,Richard J. Hayes,David Ross +8 more
TL;DR: HIV voluntary counselling and testing uptake among young people was extremely high when offered an opt-out strategy, and increased with increasing knowledge of STI acquisition (males) or pregnancy prevention (females).
Journal ArticleDOI
Microbicides Development Program, Tanzania-Baseline Characteristics of an Occupational Cohort and Reattendance at 3 Months.
Andrew Vallely,Stella Kasindi,Ian Hambleton,Louise Knight,Tobias Chirwa,Rebecca Balira,John Changalucha,Deborah Watson-Jones,Dean Everett,Awene Gavyole,Jocelyn Moyes,Mar Pujades-Rodriguez,David Ross,Richard J. Hayes +13 more
TL;DR: Baseline characteristics of this occupational group suggest their suitability for microbicide trials, and a screening round, locally appropriate informed consent procedures, and effective community tracing may help reduce losses to follow-up in such settings.
Journal ArticleDOI
Long-Term Impact of Acyclovir Suppressive Therapy on Genital and Plasma HIV RNA in Tanzanian Women: A Randomized Controlled Trial
Clare Tanton,Clare Tanton,Helen A. Weiss,Mary Rusizoka,Jérôme LeGoff,John Changalucha,Kathy Baisley,Kathy Baisley,Kokugonza Mugeye,Dean Everett,Dean Everett,Laurent Bélec,Tim Clayton,David Ross,Richard J. Hayes,Deborah Watson-Jones +15 more
TL;DR: Acyclovir administered at a dosage of 400 mg twice daily is unlikely to be a useful long-term intervention to reduce HIV transmission and may be attributable to suboptimal adherence or treatment regimen.
Journal ArticleDOI
Rapid acquisition of HPV around the time of sexual debut in adolescent girls in Tanzania
Catherine F Houlihan,Kathy Baisley,Ignacio G. Bravo,Saidi Kapiga,Silvia de Sanjosé,John Changalucha,David Ross,Richard J. Hayes,Deborah Watson-Jones +8 more
TL;DR: HP incidence was very high after first sex, including some vaccine genotypes, and infection duration was short, which supports recommendations that the HPV vaccine should be given to girls before first sex.
Journal ArticleDOI
Differences in health-related quality of life between HIV-positive and HIV-negative people in Zambia and South Africa: a cross-sectional baseline survey of the HPTN 071 (PopART) trial
Ranjeeta Thomas,Ronelle Burger,Abigail Harper,Sarah Kanema,Lawrence Mwenge,Nosivuyile Vanqa,Nomtha Bell-Mandla,Peter C. Smith,Sian Floyd,Peter Bock,Helen Ayles,Nulda Beyers,Deborah Donnell,Sarah Fidler,Richard J. Hayes,Katharina Hauck,James R Hargreaves,Deborah Watson-Jones,Peter Godfrey-Faussett,Anne Cori,Michael Pickles,Nomtha Mandla,Blia Yang,Anelet James,Redwaan Vermaak,Nozizwe Makola,Graeme Hoddinott,Vikesh Naidoo,Virginia Bond,Musonda Simwinga,Alwyn Mwinga,Barry Kosloff,Mohammed Limbada,Justin Bwalya,Chepela Ngulube,Christophe Fraser,Susan H. Eshleman,Yaw Agyei,Vanessa Cummings,Denni Catalano,Lynda Emel,Lisa Bunts,Heather Noble,David N. Burns,Alain Kouda,Niru Sista,Ayana Moore,Rhonda White,Tanette Headen,Eric Miller,Kathy Hinson,Sten H. Vermund,Mark Barnes,Lyn Horn,Albert Mwango,Megan Baldwin,Shauna Wolf,Erin Hughes +57 more
TL;DR: ART is successful in helping to reduce inequalities in HRQoL between HIV-positive and HIV-negative individuals in this general population sample, and the importance of improving awareness of HIV status and expanding ART to prevent losses in HRZoL that occur with untreated HIV progression is highlighted.